C. Rossi

发表

Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries

P. Lefebvre, D. Lin, K. Joshi, 2021, Current medical research and opinion.

Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States

P. Lefebvre, M. Lafeuille, C. Rossi, 2022, Journal of health economics and outcomes research.

Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide

P. Lefebvre, H. Hardy, M. Lafeuille, 2020, Patient preference and adherence.

Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.

N. Shore, P. Lefebvre, P. Sieber, 2022, Urology.

Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy

G. McComsey, B. Bookhart, M. Lafeuille, 2022, Infectious Diseases and Therapy.

Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States

E. Wu, A. Guérin, C. Rossi, 2022, Journal of health economics and outcomes research.

Economic Burden of Commercially Insured Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior in the United States.

P. Greenberg, J. Sheehan, C. Neslusan, 2022, The Journal of clinical psychiatry.

Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy

G. McComsey, B. Bookhart, M. Lafeuille, 2022, Infectious Diseases and Therapy.

Economic Burden Associated With Nasal Polyposis Recurrence Among Commercially Insured Patients in the United States.

P. Lefebvre, J. Suh, D. Pilon, 2022, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Incidence and economic burden of respiratory syncytial virus among adults in the United States: A retrospective analysis using 2 insurance claims databases.

L. Lamerato, P. Lefebvre, B. Bookhart, 2022, Journal of managed care & specialty pharmacy.

Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective

C. Rossi, E. Atallah, R. Maegawa, 2022, Journal of health economics and outcomes research.

Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.

E. Muser, I. Khilfeh, P. Lefebvre, 2022, Urologic oncology.

Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder

P. Lefebvre, K. Joshi, D. Pilon, 2020, Current medical research and opinion.

Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort study.

E. Muser, I. Khilfeh, P. Lefebvre, 2023, Urologic oncology.

Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamide.

I. Khilfeh, P. Lefebvre, D. Pilon, 2022, Future oncology.

Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States

P. Lefebvre, B. Bookhart, M. Lafeuille, 2021, Current medical research and opinion.

Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug–Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression

L. Citrome, J. Sheehan, P. Lefebvre, 2021, Advances in Therapy.

Medication adherence among patients with advanced prostate cancer using oral therapies.

P. Lefebvre, J. LaMori, D. Pilon, 2021, Future oncology.

Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States

G. Krishnarajah, P. Lefebvre, Jessica K. DeMartino, 2023, Open forum infectious diseases.

Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates

I. Pivneva, V. Kota, C. Rossi, 2021, Leukemia & lymphoma.

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study

P. Lefebvre, M. Lafeuille, Aurélie Côté-Sergent, 2021, Journal of health economics and outcomes research.

An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus

P. Lefebvre, H. Hardy, M. Lafeuille, 2020, Current medical research and opinion.

Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States

P. Rebeiro, B. Bookhart, M. Lafeuille, 2023, Journal of the International AIDS Society.

Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors

B. Bookhart, M. Lafeuille, C. Rossi, 2022, Journal of comparative effectiveness research.

Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions

Craig E. Nelson, P. Lefebvre, K. Joshi, 2020, Journal of Managed Care & Specialty Pharmacy.

Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.

E. Muser, I. Khilfeh, P. Lefebvre, 2023, Urologic oncology.

Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1

B. Bookhart, M. Lafeuille, C. Rossi, 2023, ClinicoEconomics and outcomes research : CEOR.

Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race

I. Khilfeh, M. Bilen, D. Pilon, 2024, ClinicoEconomics and outcomes research : CEOR.